JAK1 and malignant colon neoplasm: For this reason, we performed in vitro studies in colon cancer cells (SW-620) treated with RE to confirm and validate the specific effect of RE on decreasing the expression levels of JAK1, NFE2L2, CHKA, and BMP2 genes.